You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
隴神戎發(300534.SZ):截止2022年底元胡止痛滴丸已進入三級醫院879家,二級醫院1751家
格隆匯 07-27 11:48

格隆匯7月27日丨有投資者向隴神戎發(300534.SZ)提問:公司在提升元胡止痛滴丸產品醫院覆蓋率方面的計劃有哪些?

隴神戎發回復:公司通過整合隴神戎發、普安製藥2户企業市場渠道和營銷資源,加強“宣元組合”推廣,加強專業化團隊構建,提升產品品牌度、知名度等一系列工作,同時加強元胡止痛滴丸新增功能主治研究等,全面構建獨家品種技術壁壘,不斷提升元胡止痛滴丸產品的醫院覆蓋率。目前,元胡止痛滴丸以其產品劑型先進、效力持久、副作用小,綠色安全、服用方便等特點,在醫院終端市場的品牌認可度和知名度較高。

截止2022年底,元胡止痛滴丸已進入三級醫院879家,二級醫院1751家,其他醫療機構9220家,覆蓋率分別約佔其總量的23.64%、17.51%和13.46%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account